AngioDynamics (ANGO) befindet sich laut CEO Jim Clemmer in diesem Jahr an einem wichtigen Wendepunkt für die Unternehmensentwicklung. In…
…
…
AngioDynamics (ANGO) delivered earnings and revenue surprises of 63.64% and 2.36%, respectively, for the quarter ended November 2024. Do the…
AngioDynamics latest regulatory approval is likely to pave the way for an alternative to conventional radical surgery and improve patient…
AngioDynamics (ANGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend…
The consensus price target hints at a 94.3% upside potential for AngioDynamics (ANGO). While empirical research shows that this sought-after…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
AngioDynamics announces the receipt of CPT Category I code for IRE technology.…
AngioDynamics (ANGO) delivers decent top-line results on a pro-forma basis in first-quarter fiscal 2025, driven by strength in the Med…
…
…
AngioDynamics RECOVER-AV trial evaluates the AlphaVac F1885 Systems safety and efficacy in treating acute pulmonary embolism in Europe.…
The mean of analysts price targets for AngioDynamics (ANGO) points to a 77% upside in the stock. While this highly…
…
AngioDynamics (ANGO) registers overall strong top-line results on a pro-forma basis in fourth-quarter fiscal 2024, driven by strength in the…
Earnings call: AngioDynamics sees steady growth in FY 2024 results…
…
AngioDynamics (ANGO) announces the European CE Mark approval of its AlphaVac F1885 System, which is likely to expand the range…
…
Earnings call: AngioDynamics posts mixed Q3 results, focuses on growth…
AngioDynamics (ANGO) announces the FDAs approval of its AlphaVac F1885 System, which is likely to expand the range of therapy…
Despite strength in the Med Tech business, AngioDynamics (ANGO) registers overall soft performance in third-quarter fiscal 2024.…
…
AngioDynamics (ANGO) announces its settlement agreement with BDs affiliate, C.R. Bard, to resolve a 10-year dispute over outstanding patent litigation.…
AngioDynamics sells PICC and Midline portfolios for $45 million…
The latest trading day saw AngioDynamics (ANGO) settling at $6.09, representing a -0.98% change from its previous close.…
AngioDymics (ANGO) new FDA-approved Auryon XL Catheter is likely to boost PAD treatment by eliminating access site complications in Atherectomy…
…
Leading cardiac ablation market players include Medtronic, AngioDynamics, Atricure, Inc., Alcon, Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Medical Device…
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in second-quarter fiscal 2024.…
…
…
…
AngioDynamics (ANGO) delivered earnings and revenue surprises of 44.44% and 3.15%, respectively, for the quarter ended November 2023. Do the…
…
Companies covered in this study are Abbott, Cardinal Health, Johnson & Johnson, Medtronic, 3M, Steris, Catalent Inc., Smiths Medical Inc.,…
AngioDynamics (ANGO) closed the most recent trading day at $6.77, moving -1.31% from the previous trading session.…
In the most recent trading session, AngioDynamics (ANGO) closed at $6.74, indicating a -0.15% shift from the previous trading day.…
AngioDynamics (ANGO) closed the most recent trading day at $6.85, moving +1.33% from the previous trading session.…
In the latest trading session, AngioDynamics (ANGO) closed at $6.86, marking a -1.15% move from the previous day.…
AngioDynamics hat am 04.10.2023 die Geschäftsergebnisse zum jüngsten Jahresviertel vorgestellt.Das EPS lag bei -0,120 USD. Ein Jahr zuvor waren -0,060…
…
AngioDynamics (ANGO) closed the most recent trading day at $8.76, moving -1.35% from the previous trading session....…
AngioDynamics (ANGO) closed at $8.58 in the latest trading session, marking no change from the prior day....…
AngioDynamics Shares Up on Breakthrough Device Designation...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
In the latest trading session, AngioDynamics (ANGO) closed at $8.34, marking a +1.46% move from the previous day....…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…